Datasets:
Modalities:
Text
Formats:
csv
Languages:
English
Size:
< 1K
Tags:
biohacking
wellness-technology
structured-data
machine-readable
interoperability
reproducibility
License:
| # Holistix Open Biohacking Data Project | |
| # Source Density Upgrade Plan | |
| Project: Holistix Open Biohacking Data Project | |
| Dataset version: v1.2 | |
| Project release: v1.3 | |
| Maintainer: Holistix International | |
| Repository: https://github.com/holistixintlsite-commits/open-biohacking-data | |
| Project page: https://www.holistixintl.com/pages/open-biohacking-data-index | |
| ## Purpose | |
| This document describes the planned source-density upgrade path for the Holistix Open Biohacking Data Project. | |
| The goal is to improve source depth, citation clarity, auditability, and claim-boundary strength for the most sensitive and highest-impact dataset areas. | |
| This plan is part of the v1.3 trust layer. It does not change the current v1.2 dataset schema. It provides a public roadmap for improving source coverage and review depth over future releases. | |
| ## What Source Density Means | |
| Source density refers to the strength, number, relevance, and clarity of sources supporting a dataset row, topic group, or dataset section. | |
| A stronger source-density layer may include: | |
| * additional independent sources | |
| * regulatory or agency references | |
| * standards or technical references | |
| * manufacturer safety documentation | |
| * peer-reviewed reviews or studies where appropriate | |
| * measurement references | |
| * clearer row-level citation notes | |
| * clearer claim-boundary language | |
| * clearer safety context | |
| * clearer source-type classification | |
| The goal is not to add as many sources as possible. | |
| The goal is to add the right sources where they improve clarity, safety, auditability, and responsible interpretation. | |
| ## Why This Matters | |
| The Holistix Open Biohacking Data Project covers consumer wellness technology topics that may overlap with safety-sensitive or YMYL-adjacent areas. | |
| Examples include: | |
| * contraindications | |
| * implanted devices | |
| * eye exposure | |
| * heat exposure | |
| * respiratory sensitivity | |
| * ozone | |
| * pregnancy cautions | |
| * seizure history | |
| * cardiac concerns | |
| * device-output measurement | |
| * health-claim boundaries | |
| For these topics, stronger source density helps users understand what a dataset row means, what it does not mean, and how it should be interpreted. | |
| ## Source-Density Principles | |
| Future source upgrades should follow these principles: | |
| 1. Prioritize safety-sensitive rows first. | |
| 2. Prefer independent, regulatory, technical, or primary references where appropriate. | |
| 3. Preserve clear claim boundaries. | |
| 4. Avoid turning educational rows into medical recommendations. | |
| 5. Avoid implying product efficacy. | |
| 6. Avoid implying source endorsement of Holistix or Holistix products. | |
| 7. Preserve row-level `citation_note` context. | |
| 8. Update version history when meaningful source upgrades are made. | |
| 9. Keep commercial navigation separate from medical or safety claims. | |
| 10. Document sensitive-topic review status where appropriate. | |
| ## High-Priority Dataset Areas | |
| The following dataset areas are highest priority for future source-density upgrades. | |
| ## 1. PEMF Contraindications Database | |
| Priority level: Highest | |
| Reason: | |
| The PEMF Contraindications Database includes sensitive topics such as implanted devices, pacemakers, pregnancy, seizure history, cardiac concerns, electronic pumps, cochlear implants, oncology context, immune suppression, recent surgery, and children/minors. | |
| These are high-caution areas and should have especially strong source context. | |
| Priority rows or topic groups: | |
| * pacemakers | |
| * implanted electronic devices | |
| * electronic pumps | |
| * cochlear implants | |
| * pregnancy | |
| * seizure history | |
| * cardiac considerations | |
| * oncology context | |
| * recent surgery | |
| * children and minors | |
| Preferred future source types: | |
| * manufacturer safety manuals | |
| * medical-device safety references | |
| * regulatory or agency pages | |
| * clinical or review literature where appropriate | |
| * professional safety guidance | |
| * electromagnetic compatibility references | |
| Future upgrade goals: | |
| * add stronger row-level sources for implanted-device cautions | |
| * clarify that contraindication rows are not personalized medical advice | |
| * distinguish between general device-category caution and clinical prohibition | |
| * improve `citation_note` wording for sensitive rows | |
| * add review-status notes where appropriate | |
| ## 2. Red Light Dose Index | |
| Priority level: High | |
| Reason: | |
| The Red Light Dose Index includes terms such as wavelength, irradiance, fluence, distance, session duration, skin exposure, eye safety, and heat sensitivity. | |
| Dose-related terminology can be easily misinterpreted as treatment guidance if boundaries are not clear. | |
| Priority rows or topic groups: | |
| * irradiance | |
| * fluence | |
| * wavelength | |
| * distance | |
| * session duration | |
| * eye safety | |
| * heat sensitivity | |
| * photosensitivity context | |
| * 660 nm and 850 nm terminology | |
| * red light vs near-infrared distinction | |
| Preferred future source types: | |
| * photobiomodulation review literature | |
| * technical measurement references | |
| * device safety documentation | |
| * eye-safety references | |
| * manufacturer specification documentation | |
| * standards or technical measurement guides where appropriate | |
| Future upgrade goals: | |
| * clarify that dose terminology is educational, not dosing instruction | |
| * strengthen source context around fluence and irradiance | |
| * improve safety notes around eyes and heat sensitivity | |
| * add more measurement-focused citation notes | |
| * support future explainer pages with stronger source context | |
| ## 3. Blue Light Therapy Reference Index | |
| Priority level: High | |
| Reason: | |
| Blue light therapy topics may involve eye exposure, skin exposure, photosensitivity, acne-related claims, circadian timing, and home-use device safety. | |
| These topics require careful claim boundaries. | |
| Priority rows or topic groups: | |
| * eye exposure | |
| * photosensitivity | |
| * acne device claims | |
| * skin-care device context | |
| * circadian timing | |
| * screen blue light distinction | |
| * home-use safety | |
| * wavelength ranges | |
| Preferred future source types: | |
| * dermatology or phototherapy references | |
| * device safety references | |
| * eye exposure guidance | |
| * photosensitivity cautions | |
| * regulatory or agency material where appropriate | |
| * review literature where appropriate | |
| Future upgrade goals: | |
| * strengthen eye-safety and photosensitivity citation notes | |
| * clarify the distinction between controlled therapy devices and screen blue light | |
| * avoid disease-treatment claims | |
| * improve row-level source context for acne-related references | |
| * add clearer consumer-device boundaries | |
| ## 4. Negative Ion Safety Index | |
| Priority level: High | |
| Reason: | |
| Negative ion devices may overlap with ozone generation, indoor-air claims, respiratory sensitivity, radioactive-material concerns, surface deposition, and consumer safety. | |
| This topic is highly prone to confusing or exaggerated claims. | |
| Priority rows or topic groups: | |
| * ozone generation | |
| * ozone-free claims | |
| * respiratory sensitivity | |
| * ionizer categories | |
| * negative ion pendants | |
| * radioactive-material concerns | |
| * indoor-air claims | |
| * particle charging | |
| * surface deposition | |
| Preferred future source types: | |
| * regulatory or agency ozone references | |
| * indoor air quality references | |
| * consumer product safety references | |
| * technical references on ionization | |
| * manufacturer safety documentation | |
| * radiation/radioactive-material references where appropriate | |
| Future upgrade goals: | |
| * improve ozone-related source density | |
| * strengthen radioactive-material caution rows | |
| * clarify indoor-air claim boundaries | |
| * distinguish negative ion pendant topics from room ionizer topics | |
| * improve consumer safety notes | |
| ## 5. Infrared Therapy Reference Index | |
| Priority level: Medium to high | |
| Reason: | |
| Infrared therapy topics may involve heat exposure, sauna blankets, hydration, overheating, temperature, near-infrared and far-infrared distinctions, and photobiomodulation terminology. | |
| Heat-related risks should be clearly bounded. | |
| Priority rows or topic groups: | |
| * infrared sauna blankets | |
| * hydration | |
| * overheating | |
| * heat sensitivity | |
| * near-infrared | |
| * far-infrared | |
| * photobiomodulation distinction | |
| * sauna exposure context | |
| * device temperature context | |
| Preferred future source types: | |
| * heat exposure safety references | |
| * sauna safety references | |
| * manufacturer safety documentation | |
| * photobiomodulation literature where appropriate | |
| * technical references on infrared categories | |
| * consumer safety references | |
| Future upgrade goals: | |
| * clarify heat exposure cautions | |
| * strengthen hydration and overheating notes | |
| * separate infrared heat context from red/NIR photobiomodulation context | |
| * improve citation notes around sauna blankets | |
| * avoid treatment or detox claims | |
| ## 6. Hydrogen Water Reference Index | |
| Priority level: Medium to high | |
| Reason: | |
| Hydrogen water topics may involve dissolved hydrogen concentration, PPB, PPM, ORP, electrolysis, retention, testing methods, and measurement claims. | |
| This topic is prone to exaggerated product claims and confusing measurement language. | |
| Priority rows or topic groups: | |
| * PPB | |
| * PPM | |
| * dissolved hydrogen concentration | |
| * ORP caution | |
| * electrolysis | |
| * hydrogen retention | |
| * testing methods | |
| * device transparency | |
| * concentration claims | |
| Preferred future source types: | |
| * molecular hydrogen measurement references | |
| * technical measurement references | |
| * peer-reviewed literature where appropriate | |
| * device testing references | |
| * manufacturer documentation | |
| * chemistry references | |
| Future upgrade goals: | |
| * improve PPB/PPM source context | |
| * clarify ORP limitations | |
| * strengthen measurement and testing-method rows | |
| * avoid implied treatment claims | |
| * improve consumer-device transparency notes | |
| ## 7. Terahertz Device Reference Index | |
| Priority level: Medium | |
| Reason: | |
| Consumer terahertz wellness devices are an emerging and confusing category. Topics may involve frequency range, non-ionizing context, heating, exposure variables, and claim boundaries. | |
| This area needs especially careful language because consumer marketing can overstate certainty. | |
| Priority rows or topic groups: | |
| * terahertz frequency range | |
| * non-ionizing context | |
| * heating and exposure variables | |
| * consumer device transparency | |
| * emerging technology caution | |
| * combined-device comparisons | |
| * therapy claim boundaries | |
| Preferred future source types: | |
| * technical references on terahertz radiation | |
| * non-ionizing radiation references | |
| * exposure and heating references | |
| * standards or technical sources where appropriate | |
| * manufacturer transparency documents | |
| * review literature where appropriate | |
| Future upgrade goals: | |
| * clarify non-ionizing does not automatically mean risk-free | |
| * strengthen heating/exposure variable notes | |
| * separate physics terminology from health claims | |
| * improve citation notes around consumer wellness-device claims | |
| * avoid implying established clinical efficacy | |
| ## 8. PEMF Frequency Index | |
| Priority level: Medium | |
| Reason: | |
| The PEMF Frequency Index contains terminology such as Hz, frequency ranges, Schumann resonance terminology, waveform, intensity, field strength, and claim boundaries. | |
| Frequency rows can be misused as treatment-prescription language if not clearly bounded. | |
| Priority rows or topic groups: | |
| * Hz | |
| * frequency range | |
| * Schumann resonance | |
| * waveform | |
| * intensity | |
| * field strength | |
| * frequency vs intensity | |
| * claimed use categories | |
| * consumer-device transparency | |
| Preferred future source types: | |
| * physics or technical references | |
| * electromagnetic field measurement references | |
| * manufacturer specifications | |
| * review literature where appropriate | |
| * standards or safety references where appropriate | |
| Future upgrade goals: | |
| * clarify that frequency references are educational, not treatment prescriptions | |
| * strengthen frequency vs intensity notes | |
| * improve field-strength and waveform source context | |
| * avoid claim inflation around specific Hz values | |
| * support future glossary and explainer pages | |
| ## Source Upgrade Workflow | |
| Future source-density upgrades should follow this workflow: | |
| 1. Select one dataset or topic group. | |
| 2. Identify rows with the highest safety or claim-risk sensitivity. | |
| 3. Review current `source_name`, `source_url`, and `citation_note` fields. | |
| 4. Add or improve source references where needed. | |
| 5. Prefer sources that improve clarity and safety boundaries. | |
| 6. Update `citation_note` language to preserve claim boundaries. | |
| 7. Avoid adding sources that create misleading certainty. | |
| 8. Update the dataset CSV and JSON files if row fields change. | |
| 9. Update checksums after any dataset file changes. | |
| 10. Update version history. | |
| 11. Update Zenodo/GitHub release notes when appropriate. | |
| 12. Revalidate pages and machine-readable files. | |
| ## Source Preference Order | |
| For sensitive rows, preferred source types generally include: | |
| 1. regulatory or agency sources | |
| 2. standards or technical references | |
| 3. manufacturer safety manuals or instructions | |
| 4. peer-reviewed reviews or studies where appropriate | |
| 5. university or institutional educational references | |
| 6. measurement or technical documentation | |
| 7. project methodology or source-register notes | |
| 8. commercial category references only for navigation or commercial relevance context | |
| This preference order may vary by topic. | |
| ## What This Plan Does Not Do | |
| This plan does not: | |
| * create medical advice | |
| * create treatment recommendations | |
| * create disease-prevention guidance | |
| * create dosing protocols | |
| * create product-efficacy claims | |
| * claim independent academic consensus | |
| * claim expert medical review where none has occurred | |
| * imply source endorsement of Holistix or Holistix products | |
| * replace qualified professional guidance | |
| ## Future Release Targets | |
| Potential future release themes may include: | |
| ### v1.3 | |
| Integrity, provenance, raw links, known limitations, review policy, and source-density roadmap. | |
| ### v1.4 | |
| High-priority source-density upgrade for PEMF contraindications and red light dose terminology. | |
| ### v1.5 | |
| Source-density upgrade for blue light safety, negative ion safety, and hydrogen measurement terminology. | |
| ### v1.6 | |
| Source-density upgrade for infrared heat safety, terahertz safety context, and PEMF frequency terminology. | |
| Release numbering may change depending on project needs. | |
| ## Review and Authorship Connection | |
| Source-density upgrades should be coordinated with the project review and authorship policy. | |
| Sensitive topic pages and datasets may be marked for future expert review, advisory review, technical review, or claim-boundary review. | |
| Review status should be documented clearly and should not imply endorsement of products. | |
| ## DOI and Archive Context | |
| Current archived release DOI for the v1.3 trust-layer release: | |
| https://doi.org/10.5281/zenodo.21033668 | |
| Project DOI / all versions: | |
| https://doi.org/10.5281/zenodo.20978709 | |
| Future releases may receive additional version-specific Zenodo DOIs while the concept DOI remains the all-versions project DOI. | |
| ## Disclaimer | |
| The Holistix Open Biohacking Data Project is for educational and informational purposes only. | |
| It is not medical advice, diagnosis, treatment guidance, disease-prevention guidance, dosing guidance, clinical protocol guidance, or a substitute for consultation with a qualified healthcare professional. | |
| Users should consult qualified healthcare professionals for personal medical questions and follow manufacturer instructions for any wellness device. | |